Skip to content

A pilot study to explore the bioavailability of UMP enriched products in healthy volunteers

A pilot study to explore the bioavailability of UMP enriched products in healthy volunteers - UMP Pilot Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON36006
Enrollment
25
Registered
2011-04-08
Start date
2011-04-27
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uridine bloedbeeld na uridine monofosfaat inname Uridine bioavailability uridine blood levels

Interventions

All subjects will undergo a single intake of 125ml of the allocated study product during the study visit, and have blood sampled to determine uridine levels.

Sponsors

Danone Research - Centre for Specialised Nutrition
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -Male -Age 50-70 years, inclusive -BMI 18- 28kg/m2, inclusive -Written informed consent

Exclusion criteria

Exclusion criteria: -Any condition that may interfere with the definition *healthy volunteer* according to the investigator, with special attention to the presence of liver disease, bowel disease, diarrhea and catabolism (unintended recent weight loss) -Heavy exercise like long-distance running one week prior to the study day -The use of RNA rich nutritional supplements (such as yeast) within a period of one month prior to the start of the study -Unable to adhere to protocol instructions -Alcohol or drug abuse in the opinion of the investigator -Investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements -Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study

Design outcomes

Primary

MeasureTime frame
Changes in blood plasma levels of uridine over time, following single intake of study product.

Secondary

MeasureTime frame
N.a.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)